Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2572 | 3695 | 45.0 | 82% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2572 | 2 | UROKINASE RECEPTOR//UPAR//UPA | 3695 |
458 | 1 | UROKINASE RECEPTOR//UPAR//UPA | 3413 |
29975 | 1 | ARTIFICIAL IMMUNE COMPLEX//MICROBIOL IMMUNOL MOL GENET A68//PAI 1 TRANSCRIPTION | 177 |
34876 | 1 | GLIOBLASTOMA CELL STRAIN//UPA PROMOTER//CELL CYCLE PREVALENCE | 105 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | UROKINASE RECEPTOR | authKW | 1258616 | 5% | 81% | 188 |
2 | UPAR | authKW | 946123 | 5% | 59% | 195 |
3 | UPA | authKW | 613347 | 5% | 39% | 189 |
4 | UROKINASE | authKW | 470179 | 7% | 22% | 261 |
5 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | authKW | 423729 | 4% | 36% | 142 |
6 | UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR | authKW | 306589 | 2% | 62% | 60 |
7 | FINSEN | address | 264537 | 5% | 19% | 172 |
8 | PLASMINOGEN ACTIVATOR | authKW | 246129 | 5% | 16% | 191 |
9 | UROKINASE PLASMINOGEN ACTIVATOR | authKW | 243130 | 2% | 35% | 83 |
10 | SUPAR | authKW | 238730 | 1% | 57% | 51 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 12862 | 31% | 0% | 1161 |
2 | Hematology | 4017 | 11% | 0% | 396 |
3 | Cell Biology | 3279 | 17% | 0% | 620 |
4 | Biochemistry & Molecular Biology | 1822 | 22% | 0% | 813 |
5 | Peripheral Vascular Diseases | 1295 | 6% | 0% | 229 |
6 | Medicine, Research & Experimental | 453 | 5% | 0% | 196 |
7 | Pathology | 443 | 4% | 0% | 140 |
8 | CYTOLOGY & HISTOLOGY | 285 | 0% | 0% | 17 |
9 | Biophysics | 232 | 4% | 0% | 148 |
10 | Medical Laboratory Technology | 212 | 2% | 0% | 56 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FINSEN | 264537 | 5% | 19% | 172 |
2 | SPECIALTY CARE SERV | 57147 | 0% | 43% | 16 |
3 | COPENHAGEN BIO | 33489 | 1% | 16% | 25 |
4 | C6 | 33044 | 0% | 67% | 6 |
5 | EXPT SURG MOL ONCOL SOLID TUMORS | 33036 | 0% | 40% | 10 |
6 | MOL PATHOL MED | 32139 | 0% | 32% | 12 |
7 | SECT 3735 | 31135 | 0% | 54% | 7 |
8 | DANISH CHINESE PROTEASES CANC | 28310 | 0% | 29% | 12 |
9 | CHARITE FRANZ VOLHARD CLIN | 26437 | 0% | 80% | 4 |
10 | CANC BIOL PHARMACOL | 21491 | 1% | 11% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FIBRINOLYSIS | 42919 | 2% | 9% | 58 |
2 | FIBRINOLYSIS & PROTEOLYSIS | 9675 | 0% | 7% | 17 |
3 | CLINICAL & EXPERIMENTAL METASTASIS | 5606 | 1% | 2% | 37 |
4 | INTERNATIONAL JOURNAL OF CANCER | 5068 | 3% | 1% | 113 |
5 | THROMBOSIS AND HAEMOSTASIS | 4794 | 2% | 1% | 77 |
6 | CANCER RESEARCH | 4614 | 4% | 0% | 151 |
7 | INVASION & METASTASIS | 3163 | 0% | 3% | 13 |
8 | CANCER COMMUNICATIONS | 2905 | 0% | 6% | 6 |
9 | EXPERIMENTAL CELL RESEARCH | 2637 | 2% | 1% | 65 |
10 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2626 | 0% | 2% | 17 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UROKINASE RECEPTOR | 1258616 | 5% | 81% | 188 | Search UROKINASE+RECEPTOR | Search UROKINASE+RECEPTOR |
2 | UPAR | 946123 | 5% | 59% | 195 | Search UPAR | Search UPAR |
3 | UPA | 613347 | 5% | 39% | 189 | Search UPA | Search UPA |
4 | UROKINASE | 470179 | 7% | 22% | 261 | Search UROKINASE | Search UROKINASE |
5 | UROKINASE TYPE PLASMINOGEN ACTIVATOR | 423729 | 4% | 36% | 142 | Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR | Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR |
6 | UROKINASE TYPE PLASMINOGEN ACTIVATOR RECEPTOR | 306589 | 2% | 62% | 60 | Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR+RECEPTOR | Search UROKINASE+TYPE+PLASMINOGEN+ACTIVATOR+RECEPTOR |
7 | PLASMINOGEN ACTIVATOR | 246129 | 5% | 16% | 191 | Search PLASMINOGEN+ACTIVATOR | Search PLASMINOGEN+ACTIVATOR |
8 | UROKINASE PLASMINOGEN ACTIVATOR | 243130 | 2% | 35% | 83 | Search UROKINASE+PLASMINOGEN+ACTIVATOR | Search UROKINASE+PLASMINOGEN+ACTIVATOR |
9 | SUPAR | 238730 | 1% | 57% | 51 | Search SUPAR | Search SUPAR |
10 | UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR | 232105 | 1% | 59% | 48 | Search UROKINASE+PLASMINOGEN+ACTIVATOR+RECEPTOR | Search UROKINASE+PLASMINOGEN+ACTIVATOR+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ANDREASEN, PA , KJOLLER, L , CHRISTENSEN, L , DUFFY, MJ , (1997) THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER METASTASIS: A REVIEW.INTERNATIONAL JOURNAL OF CANCER. VOL. 72. ISSUE 1. P. 1-22 | 231 | 72% | 1159 |
2 | MEKKAWY, AH , POURGHOLAMI, MH , MORRIS, DL , (2014) INVOLVEMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER: AN OVERVIEW.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 5. P. 918 -956 | 229 | 74% | 25 |
3 | ULISSE, S , BALDINI, E , SORRENTI, S , D'ARMIENTO, M , (2009) THE UROKINASE PLASMINOGEN ACTIVATOR SYSTEM: A TARGET FOR ANTI-CANCER THERAPY.CURRENT CANCER DRUG TARGETS. VOL. 9. ISSUE 1. P. 32 -71 | 274 | 56% | 144 |
4 | BOONSTRA, MC , VERSPAGET, HW , GANESH, S , KUBBEN, FJGM , VAHRMEIJER, AL , DE VELDE, CJHV , KUPPEN, PJK , QUAX, PHA , SIER, CFM , (2011) CLINICAL APPLICATIONS OF THE UROKINASE RECEPTOR (UPAR) FOR CANCER PATIENTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 19. P. 1890-1910 | 216 | 79% | 14 |
5 | SMITH, HW , MARSHALL, CJ , (2010) REGULATION OF CELL SIGNALLING BY UPAR.NATURE REVIEWS MOLECULAR CELL BIOLOGY. VOL. 11. ISSUE 1. P. 23 -36 | 123 | 71% | 331 |
6 | CARRIERO, MV , STOPPELLI, MP , (2011) THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND THE GENERATION OF INHIBITORS OF UROKINASE ACTIVITY AND SIGNALING.CURRENT PHARMACEUTICAL DESIGN. VOL. 17. ISSUE 19. P. 1944 -1961 | 181 | 76% | 22 |
7 | BLASI, F , SIDENIUS, N , (2010) THE UROKINASE RECEPTOR: FOCUSED CELL SURFACE PROTEOLYSIS, CELL ADHESION AND SIGNALING.FEBS LETTERS. VOL. 584. ISSUE 9. P. 1923 -1930 | 108 | 92% | 129 |
8 | ARCHINTI, M , BRITTO, M , EDEN, G , FURLAN, F , MURPHY, R , DEGRYSE, B , (2011) THE UROKINASE RECEPTOR IN THE CENTRAL NERVOUS SYSTEM.CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS. VOL. 10. ISSUE 2. P. 271 -294 | 205 | 60% | 7 |
9 | HOYER-HANSEN, G , LUND, IK , (2007) UROKINASE RECEPTOR VARIANTS IN TISSUE AND BODY FLUIDS.ADVANCES IN CLINICAL CHEMISTRY, VOL 44. VOL. 44. ISSUE . P. 65 -102 | 137 | 88% | 40 |
10 | SIDENIUS, N , BLASI, F , (2003) THE UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER: RECENT ADVANCES AND IMPLICATION FOR PROGNOSIS AND THERAPY.CANCER AND METASTASIS REVIEWS. VOL. 22. ISSUE 2-3. P. 205-222 | 130 | 81% | 259 |
Classes with closest relation at Level 2 |